George Beurling was one of the most lethal Allied fighter pilots of World War Two and one of the most difficult to command.
Bristol Myers Squibb and Johnson & Johnson have said they will stop development of their oral Factor XIa inhibitor milvexian in acute coronary syndrome after a disappointing trial result. The decision ...